STOCK TITAN

bvxv - bvxv STOCK NEWS

Welcome to our dedicated news page for bvxv (Ticker: bvxv), a resource for investors and traders seeking the latest updates and insights on bvxv.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect bvxv's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of bvxv's position in the market.

-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.3%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.44%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BiondVax Pharmaceuticals announced additional results in a preclinical proof-of-concept study of its innovative inhaled NanoAb COVID-19 drug. The study showed that hamsters administered the NanoAb three hours prior to infection experienced no significant weight loss, while the untreated control group experienced a 12% average weight loss. The NanoAb also led to milder illness, faster recovery, and lower viral lung titer compared to the placebo group. BiondVax plans to conduct a first-in-human Phase 1/2a clinical trial in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.18%
Tags
covid-19
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.17%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.45%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.61%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.09%
Tags
bvxv

Nasdaq:BVXV

BVXV Rankings

BVXV Stock Data

4.97M
2.72M
20.02%
10.69%
0.13%